Jay SinhaSenior Director, Biologics CMC Development and Manufacturing at Celldex TherapeuticsSpeaker
Profile
Jay Sinha is a Sr. Director at Celldex therapeutics, a well-known biopharmaceutical company with primary therapeutic focus in inflammatory diseases with inadequate treatment options. He leads the late-stage biologics CMC development and has approximately 20+ years of experience in the biopharmaceutical industry. Earlier, he graduated with a Ph.D. degree in Chemical Engineering.
Agenda Sessions
Development of a tangential flow filtration process for monoclonal/bi-specific antibody formulation
, 13:00View Session